Table 2.
Measures and assessment schedule.
| Measure | Baseline | 3-, 6-, & 9-month follow-ups |
|---|---|---|
| COVID-19 impact | X | |
| Demographics | X | |
| Psychiatric diagnosis (anxiety/depression) | X | |
| Substance use | ||
| Alcohol use | X | |
| Drug use | X | |
| Protective factors | ||
| Mental health recovery | X | X |
| Resilience | X | |
| Self-efficacy | X | |
| Risk factors | ||
| Functioning and impairments | X | X |
| LGBTQ+ discrimination | X | X |
| LGBTQ+ stigmatization | X | X |
| Exposure to trauma | X | |
| Primary outcomes (rater) | ||
| Anxiety | X | X |
| Depression | X | X |
| Secondary outcomes (self-report) | ||
| Anxiety | X | X |
| Depression | X | X |
| ABBT mechanisms | ||
| Experiential avoidance | X | X |
| Perceived social support | X | X |
| Treatment utilization | ||
| Use of psychiatric medication | X | X |
| Receipt of psychiatric services | X | X |
| ABBT acceptability | ||
| ABBT participant exit interviews | 9-month | |
| Satisfaction | 9-month | |